Anaplastic Oligodendroglioma — Trials

Anaplastic Oligodendroglioma — Trials · CancerIndex

Clinical trials

Registered studies

100 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 18%
Top sponsor: Children's Oncology Group
Termination share: 39.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (26)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01656980	Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma	unknown	Phase 3	236	Shandong Lanjin Pharmaceuticals Co.,LtdINDUSTRY	1	Aug 3, 2012	clinicaltrials

Data updated 22 days agoSource updated Aug 3, 2012source: clinicaltrials